1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends

SWOT: e-Therapeutics Plc (ETX)

  • August 2017
  • 43 pages
  • ID: 344048
In this report:
According to the Congressional Budget Office, if the growth in healthcare spending continues at its current pace, CMS spending and private health costs will increase from the current ##% of GDP to ##% in 2025.
According to the US government's Center for Medicare and Medicaid Services (CMS), healthcare expenditure in the country rose recently ##.##% to surpass US$## trillion and represented ##% of the country's GDP.

Summary

Table of Contents

Search Inside

e-Therapeutics Plc - Financial and Strategic SWOT Analysis Review offers you an detailed tactical SWOT analysis of the company's businesses and operations. GlobalData compiled for you a well drafted, clear and easy-to- read overview of the company describing its main strengths, threats, weaknesses and opportunities. Get a better understanding of your competitors, clients and partners, and devise your own strategies to increase your business thanks to the profile..

Crucial business information covered in this profile are:

- Business overview - A comprehensive description of the company's operations and business divisions.

- Business strategy - Analyst's summarization of the corporate's business strategy.

- SWOT study - A comprehensive analysis of the company's strenghts, weakness, possibilities and segment risks.

- Company history - List of key events combined with the company.

- Main products and services - A lit of main products, services and brands of the company.

- Main competitors - A list of main competitors to the company.

- Main employees - A list of the main executives of the company.

- Executive biographies - A summary of the executives' employment history.

- Key operational heads - A list of personnel heading top departments/functions.

- Significant locations and subsidiaries - An inventory and contatct details of main locations and key partners (subsidiaries of the company).

- Main manufacturing facilities - A list of main manufacturing facilities of the company.

- Exhaustive financial ratios for the past five years - The up-to-date financial ratios derived from the annual financial statements edited by the company with 5 years history.

- Interim ratios for the final five interim periods - The recent financial ratios obtained from the quartely/semi-annual financial statements edited by the company for 5 interims history.

Key Findings

e-Therapeutics Plc is a drug discovery and development company with focus on the treatment of cancer and neurodegeneration. It has a proprietary discovery platform established on network pharmacology and chemical biology for the discovery of drugs. The company focuses on immuno-oncology to tackle drug resistance in targeted cancer therapies and anti-infectives. Its pipeline candidates contain ETX1153c, ETS2101 and ETS6103. e-Therapeutics has development centers in Oxford and Newcastle. The company operates through one subsidiary, InRotis Technologies Limited. e-Therapeutics is based in Long Hanborough, England, the UK.

e-Therapeutics Plc Key Recent Developments

Jul 24,2017: e-Therapeutics Announces Outcome of Strategic Review and Future Plans

Apr 19,2017: e-Therapeutics: Full Year Results

Apr 06,2017: e-Therapeutics : Appointment of Chief Executive Officer

Feb 16,2017: e-Therapeutics Announces Directorate Change

Jan 09,2017: e-Therapeutics: Appointment of Amgen Executive Director as Chief Executive

Main advantages of acquiring this profile are:

Get access to comprehensive data about the company's operations to detect future clients and suppliers.

- The industry profile examines the corporate's business structure, operations, main products and services, prospects, areas and subsidiaries, main executives and their biographies and key players.

Get a clear picture of your competitive environment and capitalize on your competitors' soft spots. Stay updated on the main improvements affecting the firm.

- The company's core strengths and weaknesses and areas of improvement or decline are analyzed and exhibited in the industry profile equitably. You can follow the key events thanks to the latest activities of the firm included in this profile.

Get access to comprehensive data that helps you devise your strategies better and make your business operations more lucrative..

- Alternatives that the company can explore and exploit are sized up and its development potential evaluated in the industry profile. Technological risks as well as competitive challenges are underligned.

Investigate for potential investments and opportunities, with a comprehensive overview of the companies' strategic, financial and operational performance.

- Financial ratio presented for main public companies in the industry profile contain the revenue trends, profitability, increase, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key aspects into the company for academic purposes or business purposes.

- Key elements such as swot review, business strategy and financial ratios and charts are including in the industry profile to help your academic or business needs.

Note: Some parts may be removed if info is not available for the company

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 24h.


Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Amrita helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Gilead Sciences, Inc.: Financial Highlights

  • $ 350
  • Company report
  • October 2017
  • by MarketLine

Gilead Sciences, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportSummaryMarketline’s Gilead Sciences, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and ...

CSL Limited: Financial Highlights

  • $ 350
  • Company report
  • October 2017
  • by MarketLine

CSL Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportSummaryMarketline’s CSL Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report ...

Five Prime Therapeutics, Inc.: Financial Highlights

  • $ 350
  • Company report
  • October 2017
  • by MarketLine

Five Prime Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportSummaryMarketline’s Five Prime Therapeutics, Inc. Mergers & Acquisitions (M&A), Partnerships ...


ref:plp2017

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.